ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	8/19	157/7206	2.62036441227e-09
ko05164	Influenza A	7/19	167/7206	1.26234372186e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	7/19	191/7206	3.16921926551e-07
ko05160	Hepatitis C	6/19	153/7206	1.79369653737e-06
ko04620	Toll-like receptor signaling pathway	5/19	100/7206	4.63890633877e-06
ko04380	Osteoclast differentiation	5/19	134/7206	1.94590763564e-05
ko05131	Shigellosis	4/19	82/7206	5.30147161919e-05
ko05161	Hepatitis B	5/19	173/7206	6.66084803615e-05
ko04662	B cell receptor signaling pathway	4/19	88/7206	6.99743443537e-05
ko05152	Tuberculosis	5/19	187/7206	9.64799791503e-05
ko04064	NF-kappa B signaling pathway	4/19	96/7206	9.83578066168e-05
ko04623	Cytosolic DNA-sensing pathway	3/19	41/7206	0.000155529970913
ko04668	TNF signaling pathway	4/19	120/7206	0.000233635324071
ko05162	Measles	4/19	120/7206	0.000233635324071
ko05142	Chagas disease (American trypanosomiasis)	4/19	130/7206	0.000317693800873
ko04622	RIG-I-like receptor signaling pathway	3/19	62/7206	0.000532811145936
ko04722	Neurotrophin signaling pathway	4/19	160/7206	0.000699321435215
ko05014	Amyotrophic lateral sclerosis (ALS)	3/19	74/7206	0.000895157854699
ko05134	Legionellosis	3/19	74/7206	0.000895157854699
ko04217	Necroptosis	4/19	178/7206	0.00104332385635
ko04210	Apoptosis	4/19	180/7206	0.00108776415528
ko04932	Non-alcoholic fatty liver disease (NAFLD)	4/19	182/7206	0.001133527633
ko05168	Herpes simplex infection	4/19	182/7206	0.001133527633
ko05132	Salmonella infection	3/19	98/7206	0.00201793680932
ko04660	T cell receptor signaling pathway	3/19	124/7206	0.00394009757031
ko05145	Toxoplasmosis	3/19	126/7206	0.00412168910078
ko04933	AGE-RAGE signaling pathway in diabetic complications	3/19	135/7206	0.00500207769577
ko04931	Insulin resistance	3/19	137/7206	0.00521202241295
ko05203	Viral carcinogenesis	4/19	277/7206	0.00524308717385
ko05166	HTLV-I infection	4/19	292/7206	0.00631976830558
ko04215	Apoptosis - multiple species	2/19	47/7206	0.00663465263627
ko04071	Sphingolipid signaling pathway	3/19	162/7206	0.00829443569203
ko05418	Fluid shear stress and atherosclerosis	3/19	173/7206	0.00992979243236
ko04060	Cytokine-cytokine receptor interaction	3/19	191/7206	0.0129897666534
ko04072	Phospholipase D signaling pathway	3/19	197/7206	0.0141179394836
ko04062	Chemokine signaling pathway	3/19	201/7206	0.0149005280586
ko05140	Leishmaniasis	2/19	75/7206	0.0163011638937
ko01524	Platinum drug resistance	2/19	76/7206	0.016715586025
ko05220	Chronic myeloid leukemia	2/19	85/7206	0.0206461098122
ko05210	Colorectal cancer	2/19	86/7206	0.0211047021918
ko04657	IL-17 signaling pathway	2/19	87/7206	0.0215675819406
ko05133	Pertussis	2/19	87/7206	0.0215675819406
ko05222	Small cell lung cancer	2/19	89/7206	0.0225061106474
ko04920	Adipocytokine signaling pathway	2/19	89/7206	0.0225061106474
ko05120	Epithelial cell signaling in Helicobacter pylori infection	2/19	92/7206	0.0239454804982
ko04650	Natural killer cell mediated cytotoxicity	2/19	97/7206	0.0264271110174
ko05100	Bacterial invasion of epithelial cells	2/19	99/7206	0.0274481737016
ko05146	Amoebiasis	2/19	99/7206	0.0274481737016
ko01521	EGFR tyrosine kinase inhibitor resistance	2/19	106/7206	0.031146464669
ko05215	Prostate cancer	2/19	111/7206	0.033903673134
ko05200	Pathways in cancer	4/19	492/7206	0.0366224328597
ko04666	Fc gamma R-mediated phagocytosis	2/19	122/7206	0.0402940849233
ko04211	Longevity regulating pathway	2/19	123/7206	0.04089644691
ko01522	Endocrine resistance	2/19	124/7206	0.0415022887025
ko04630	Jak-STAT signaling pathway	2/19	132/7206	0.0464718656971